MPO and COVID-19: Interestingly, recent work by Teo et al. found that increased MPO levels correlated with increased circulating levels of soluble glycocalyx components in COVID-19 patients, and that in vitro inhibition of MPO leads to reduced endothelial shedding of syndecan-1 [133].